Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Integration of Precision Medicine for Improving Management of Chronic Obstructive Pulmonary Disease (COPD)
EF 2021-22
Résumé
Chronic obstructive pulmonary disease (COPD) is a chronic lung condition characterised by obstructed airflow from the lungs that makes it difficult to breathe. COPD affects the lives of 2.6 million Canadians and is punctuated by an acute worsening of symptoms referred to as exacerbations which considerably deteriorates quality of life. It is already the leading cause of medical hospitalizations in Canada but its burden on our healthcare system continues to increase given the clear gaps in care. Clinical prediction tools can be used to accurately predict a patients risk of experiencing an exacerbation using their own health data which enables the personalisation of care to reduce the likelihood of future exacerbations. Despite the promises, clinical prediction tools are not routinely used in COPD and current management fails to consider the important individual differences between patients. My research will examine a new prediction tool developed to address this gap in care, the ACute COPD Exacerbation Prediction Tool (ACCEPT). Specifically, I will ensure that ACCEPT is up to date with contemporary Canadian clinical data by updating it using data from five major COPD research trials and compare ACCEPT against competing risk prediction methods in terms of their potential usefulness in a real-world clinical setting. Additionally, I will also develop a patient-friendly risk communication tool to facilitate shared decision-making. My research will inform an upcoming clinical trial to evaluate the impact of incorporating exacerbation risk prediction with ACCEPT into routine COPD care in British Columbia. This is a critical component of integrating clinical prediction tools into the routine management of COPD and has real possibility to improve patient care and outcomes.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466629
Name
Ho Khoa N
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Integration of Precision Medicine for Improving Management of Chronic Obstructive Pulmonary Disease (COPD)
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Copd Exacerbation Prediction Tool (Accept); Chronic Obstructive Pulmonary Disease (Copd); Clinical Prediction Model; Clinical Prediction Tool; Decision Curve Analysis; Electronic Health Records; Exacerbation; Net Benefit; Predictive Analytics; Risk Stratification
Abstract
Chronic obstructive pulmonary disease (COPD) is a chronic lung condition characterised by obstructed airflow from the lungs that makes it difficult to breathe. COPD affects the lives of 2.6 million Canadians and is punctuated by an acute worsening of symptoms referred to as exacerbations which considerably deteriorates quality of life. It is already the leading cause of medical hospitalizations in Canada but its burden on our healthcare system continues to increase given the clear gaps in care. Clinical prediction tools can be used to accurately predict a patients risk of experiencing an exacerbation using their own health data which enables the personalisation of care to reduce the likelihood of future exacerbations. Despite the promises, clinical prediction tools are not routinely used in COPD and current management fails to consider the important individual differences between patients. My research will examine a new prediction tool developed to address this gap in care, the ACute COPD Exacerbation Prediction Tool (ACCEPT). Specifically, I will ensure that ACCEPT is up to date with contemporary Canadian clinical data by updating it using data from five major COPD research trials and compare ACCEPT against competing risk prediction methods in terms of their potential usefulness in a real-world clinical setting. Additionally, I will also develop a patient-friendly risk communication tool to facilitate shared decision-making. My research will inform an upcoming clinical trial to evaluate the impact of incorporating exacerbation risk prediction with ACCEPT into routine COPD care in British Columbia. This is a critical component of integrating clinical prediction tools into the routine management of COPD and has real possibility to improve patient care and outcomes.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ho, Khoa N
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~